Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,505
+$12,525 QoQ
Shares Held
190
+9.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#490
of 593 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Basecamp Wealth Advisors LLC holds $1,654,814 across 20 Diagnostics & Research names. GH ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
833 | $438,524 | |
| 2 | DHR |
Danaher Corp /De/
|
2,050 | $390,484 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
610 | $305,829 | |
| 4 | QGEN |
Qiagen N.V.
|
2,534 | $99,079 | |
| 5 | LH |
Labcorp Holdings Inc.
|
243 | $68,040 | |
| 6 | A |
Agilent Technologies, Inc.
|
510 | $67,743 | |
| 7 | WAT |
Waters Corp /De/
|
179 | $67,132 | |
| 8 | ICLR |
Icon PLC
|
328 | $56,976 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,505 | 190 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,980 | 173 | Shares | Sole | 2026-06-24 | |
| 2025-12-31 | $17,057 | 167 | Shares | Sole | 2026-06-24 | |
| No filing history on record for this holder in this stock. | ||||||